跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
FANTIVIR
Approved
STANDARD
FANTIVIR
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2829e6450f07d348
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
2829e6450f07d348
Product Name
FANTIVIR
Artg Id
177004
Artg Name
FANTIVIR famciclovir 125 mg tablet blister pack
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2012-08-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2829e6450f07d348
Type
Standard
Back to TGA Approvals
FANTIVIR - TGA Drug Approval Details